Clinical Trials Logo

Clinical Trial Summary

Higher numbers of oocytes have not been shown to increase implantation or live newborn rates, but higher numbers of oocytes are likely to be beneficial in certain treatments. These clinical cases where a high ovarian response can be IVF cycles with genetic diagnosis, patients who need more than one pregnancy or, as in our case, oocyte donation. For this reason, and based on previous studies, investigators intend to increase the ovarian response by increasing the dose of follitropin. This clinical trial aims to evaluate high doses of Rekovelle (follitropin delta) to obtain an average of 17 oocytes in a population of oocyte donors, without affecting the health of the patients.


Clinical Trial Description

IVF ovarian stimulation cycles has been shown that the individualization of the medication doses provides clinical results comparable to conventional ovarian stimulation regimens, but also it results in greater treatment safety by significantly reducing the percentage of patients with responses extreme ovaries, and cycle cancellations. These studies have been carried out with the premise that an optimal ovarian response results in obtaining 8-14 oocytes per puncture. Although it has also been shown that larger numbers of oocytes do not increase clinical variables such as implantation rates or live newborn per cycle, it is possible that these numbers of oocytes are insufficient in specific circumstances, for example, patients with a desire to have more pregnancy, patients undergoing IVF cycles with PGT-A, or gamete donors. For these reasons, and thanks to the improvements in cryopreservation programs and the induction of oocyte maturation with GnRH agonists, it is necessary to design protocols for the individualization of doses of medication aimed at obtaining greater quantities of oocytes. The objective of this pilot study is the evaluation of higher doses of Rekovelle (follitropin delta) aimed at obtaining 17 oocytes in voluntary donors. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04778358
Study type Interventional
Source IVI Madrid
Contact
Status Completed
Phase Phase 2
Start date September 28, 2021
Completion date June 16, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT05969574 - Is Decreased Ovarian Reserve Related to an Increased Number of Previous Early Miscarriages?
Completed NCT04052464 - The Study of the Implantation Window From Endometrial Biopsy With Gene Expression Methods
Completed NCT04108039 - Micronized Progesterone vs Gonadotropin-releasing Hormone (GnRH) Antagonist in Freeze-all IVF Cycles. N/A
Suspended NCT04669652 - Evaluating Piezo-ICSI. - The EPI Study. N/A
Completed NCT04524026 - RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2 Phase 2
Recruiting NCT05981898 - Opt-IVF Multi-center Trial 2 Including All Protocols N/A
Recruiting NCT05737381 - Quality of Human Embryos in IVF, Culturing in Differentiated Oxygen N/A
Recruiting NCT04447872 - The LUTEAL Trial: Luteal Stimulation vs. Estrogen Priming Protocol N/A
Completed NCT04425317 - Detection of SARS-CoV-2 in Follicular Fluid and Cumulus-oocyte-complexes in COVID-19 Patients N/A
Not yet recruiting NCT05932082 - The Impact of Myomectomy on IVF Outcomes N/A
Not yet recruiting NCT04283435 - Endometrial Effects of Sildenafil in Frozen-Thawed Cycles in Women With Thin Endometrium Phase 1
Recruiting NCT04654741 - The Rate of Embryo Euploidy in Progestin-primed Ovarian Stimulation Cycles Phase 4
Completed NCT04099784 - Health of Frozen Transferred Versus Fresh Transferred Children
Recruiting NCT05788822 - MVA to Improve the Pregnancy Outcome in Aged Infertility Women With Assisted Reproductive Technology N/A
Completed NCT04956848 - Comparing KIDScoreā„¢ D5 and iDAScore®. The KiDA Study N/A
Not yet recruiting NCT06048666 - Platelet Rich Plasma on Ovarian Reserve Parameters and Intra Cytoplasmic Sperm Injection Outcomes in Patients With Diminished Ovarian Reserve Phase 3
Not yet recruiting NCT05954962 - Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation. Phase 4
Not yet recruiting NCT02698488 - Embryo Selection by Metabolomic Profiling of Embryo Culture Medium With Mass Spectroscopy as an Adjunct to Morphology N/A
Completed NCT01385618 - Gene-polymorphisms Relating to Human Subfertility N/A
Recruiting NCT05893238 - Human Follicular Fluid Markers and Reproductive Outcomes in IVF